<img data-src="https://cdn.ainvest.com/articles/focusnews/coverimage/content/articles/focusnews/coverimage/content/panzhognbao_f61a563f1752200615853.png" style="display: none;"><visualization data="{&quot;components&quot;: [{&quot;show_type&quot;: &quot;container2&quot;, &quot;uuid&quot;: &quot;323c43bc-3986-4eab-9b86-0e3bed7bc743&quot;}, {&quot;category&quot;: &quot;generic&quot;, &quot;chart_type&quot;: &quot;&quot;, &quot;config&quot;: {&quot;image&quot;: &quot;https://lh-prod-mid-pub-newsf10.s3.amazonaws.com/logo/INKT.png&quot;, &quot;marketTag&quot;: &quot;NASDAQ&quot;, &quot;show_type_id&quot;: 702, &quot;tradeClass&quot;: &quot;intraday&quot;, &quot;title&quot;: &quot;K\u7ebf\u56feV2&quot;, &quot;showBottom&quot;: true, &quot;score&quot;: 20, &quot;show_type&quot;: &quot;kline3&quot;, &quot;variety&quot;: &quot;stock&quot;, &quot;scoreRuleNames&quot;: &quot;&quot;, &quot;tradeStatus&quot;: &quot;trading&quot;, &quot;codeName&quot;: &quot;Name&quot;, &quot;klineDefaultType&quot;: &quot;fs&quot;, &quot;title_config&quot;: {&quot;config&quot;: {&quot;display&quot;: true, &quot;display2&quot;: false, &quot;txt_style&quot;: 0, &quot;url&quot;: &quot;&quot;}, &quot;data&quot;: {&quot;h1&quot;: &quot;INKT Trend&quot;, &quot;h2&quot;: &quot;&quot;}, &quot;show_type&quot;: &quot;title1&quot;}}, &quot;data&quot;: {&quot;chunks_info&quot;: &quot;[]&quot;, &quot;code_count&quot;: 1, &quot;columns&quot;: [{&quot;index_name&quot;: &quot;code&quot;, &quot;key&quot;: &quot;code&quot;, &quot;label&quot;: &quot;hq_code&quot;, &quot;source&quot;: &quot;fixed_index&quot;, &quot;type&quot;: &quot;STR&quot;}, {&quot;domain&quot;: &quot;abs_\u56fd\u9645\u7f8e\u80a1\u9886\u57df&quot;, &quot;feKey&quot;: &quot;Ticker&quot;, &quot;index_name&quot;: &quot;Ticker&quot;, &quot;key&quot;: &quot;Ticker&quot;, &quot;label&quot;: &quot;code&quot;, &quot;origin_index&quot;: &quot;stock code&quot;, &quot;source&quot;: &quot;fixed_index&quot;, &quot;type&quot;: &quot;STR&quot;, &quot;unit&quot;: &quot;&quot;}, {&quot;domain&quot;: &quot;abs_\u56fd\u9645\u7f8e\u80a1\u9886\u57df&quot;, &quot;feKey&quot;: &quot;Name&quot;, &quot;index_name&quot;: &quot;Name&quot;, &quot;key&quot;: &quot;Name&quot;, &quot;label&quot;: &quot;name&quot;, &quot;origin_index&quot;: &quot;stock name&quot;, &quot;source&quot;: &quot;fixed_index&quot;, &quot;type&quot;: &quot;STR&quot;, &quot;unit&quot;: &quot;&quot;}, {&quot;feKey&quot;: &quot;Date&quot;, &quot;index_name&quot;: &quot;Date&quot;, &quot;key&quot;: &quot;Date&quot;, &quot;label&quot;: &quot;date&quot;, &quot;origin_index&quot;: &quot;Date&quot;, &quot;type&quot;: &quot;DATE&quot;}, {&quot;domain&quot;: &quot;abs_\u56fd\u9645\u7f8e\u80a1\u9886\u57df&quot;, &quot;feKey&quot;: &quot;Closing Price&quot;, &quot;index_name&quot;: &quot;Closing Price&quot;, &quot;key&quot;: &quot;Closing Price&quot;, &quot;label&quot;: &quot;NoIndent&quot;, &quot;source&quot;: &quot;&quot;, &quot;timestamp&quot;: &quot;&quot;, &quot;type&quot;: &quot;DOUBLE&quot;, &quot;unit&quot;: &quot;USD&quot;}, {&quot;index_name&quot;: &quot;market_code&quot;, &quot;key&quot;: &quot;market_code&quot;, &quot;type&quot;: &quot;STR&quot;}], &quot;condition&quot;: &quot;[{\&quot;sonSize\&quot;:2,\&quot;opName\&quot;:\&quot;and\&quot;,\&quot;relatedSize\&quot;:0},{\&quot;sonSize\&quot;:0,\&quot;indexName\&quot;:\&quot;\u56fd\u9645\u7f8e\u80a1@stock code\&quot;,\&quot;indexProperties\&quot;:[\&quot;EQUAL INKT.O\&quot;],\&quot;indexPropertiesMap\&quot;:{\&quot;EQUAL\&quot;:\&quot;INKT.O\&quot;},\&quot;domain\&quot;:\&quot;abs_\u56fd\u9645\u7f8e\u80a1\u9886\u57df\&quot;,\&quot;relatedSize\&quot;:0},{\&quot;sonSize\&quot;:0,\&quot;indexName\&quot;:\&quot;\u56fd\u9645\u7f8e\u80a1@Closing Price\&quot;,\&quot;indexProperties\&quot;:[\&quot;\u8d77\u59cb\u4ea4\u6613\u65e5\u671f 20250715\&quot;,\&quot;\u622a\u6b62\u4ea4\u6613\u65e5\u671f 20250715\&quot;],\&quot;indexPropertiesMap\&quot;:{\&quot;\u8d77\u59cb\u4ea4\u6613\u65e5\u671f\&quot;:\&quot;20250715\&quot;,\&quot;\u622a\u6b62\u4ea4\u6613\u65e5\u671f\&quot;:\&quot;20250715\&quot;},\&quot;domain\&quot;:\&quot;abs_\u56fd\u9645\u7f8e\u80a1\u9886\u57df\&quot;,\&quot;relatedSize\&quot;:0}]&quot;, &quot;dataSize&quot;: 1, &quot;datas&quot;: [{&quot;code&quot;: &quot;INKT&quot;, &quot;Ticker&quot;: &quot;INKT.O&quot;, &quot;market_code&quot;: &quot;186&quot;, &quot;Closing Price&quot;: &quot;28.664&quot;, &quot;Date&quot;: &quot;20250715&quot;, &quot;Name&quot;: &quot;MiNK Therapeutics&quot;}], &quot;meta&quot;: {&quot;extra&quot;: {}}, &quot;row_count&quot;: 1, &quot;status_code&quot;: 0, &quot;status_msg&quot;: &quot;ok&quot;}, &quot;data_config&quot;: {&quot;data_ext_params&quot;: {&quot;merge_repeat&quot;: false, &quot;expand_index&quot;: false, &quot;data_add&quot;: 0, &quot;add_index&quot;: 0}, &quot;query_type&quot;: &quot;intusstock&quot;}, &quot;kline&quot;: true, &quot;renderBy&quot;: &quot;rule&quot;, &quot;show_type&quot;: &quot;jgyKline3&quot;, &quot;support_refresh&quot;: false, &quot;unique_key&quot;: &quot;1150938d6d12b088&quot;, &quot;uuid&quot;: &quot;ba0288f58835cd39&quot;, &quot;title_config&quot;: {&quot;config&quot;: {&quot;display&quot;: true, &quot;display2&quot;: false, &quot;txt_style&quot;: 0, &quot;url&quot;: &quot;&quot;}, &quot;data&quot;: {&quot;h1&quot;: &quot;INKT Trend&quot;, &quot;h2&quot;: &quot;&quot;}, &quot;show_type&quot;: &quot;title1&quot;}}], &quot;global&quot;: {&quot;query_type&quot;: &quot;intusstock&quot;}, &quot;page&quot;: {&quot;layout&quot;: {&quot;layout_data&quot;: &quot;[{\&quot;children\&quot;: [{\&quot;uuid\&quot;: \&quot;ba0288f58835cd39\&quot;, \&quot;children\&quot;: [], \&quot;showType\&quot;: \&quot;\&quot;}], \&quot;showType\&quot;: \&quot;container2\&quot;, \&quot;uuid\&quot;: \&quot;323c43bc-3986-4eab-9b86-0e3bed7bc743\&quot;}]&quot;}, &quot;render_for&quot;: &quot;aigc&quot;}, &quot;query_condition&quot;: {&quot;model_condition&quot;: null, &quot;uuids&quot;: [&quot;323c43bc-3986-4eab-9b86-0e3bed7bc743&quot;, &quot;ba0288f58835cd39&quot;], &quot;domain&quot;: &quot;intusstock&quot;, &quot;query&quot;: null}, &quot;model_condition&quot;: null, &quot;model&quot;: null, &quot;data_config&quot;: {&quot;data_ext_params&quot;: {&quot;merge_repeat&quot;: false, &quot;expand_index&quot;: false, &quot;data_add&quot;: 0, &quot;add_index&quot;: 0}, &quot;query_type&quot;: &quot;intusstock&quot;}, &quot;answer_list&quot;: null, &quot;title&quot;: null}"></visualization> • <a data-code="INKT" data-position="stock.4" data-marketid="186" data-stockname="MiNK Therapeutics" data-type="stock" href="#*f:INKT:sc*#">INKT</a> shares crater 29.89% to $28.47 after opening at $32.90 • Peer-reviewed success in testicular cancer case offsets institutional selling concerns<br• $50M ATM offering raises liquidity questions amid short-term debt pressures Today’s brutal selloff in <a data-code="INKT" data-position="stock.1" data-marketid="186" data-stockname="MiNK Therapeutics" data-type="stock" href="#*f:INKT:sc*#">MiNK Therapeutics</a> erases nearly a third of its value, with shares hitting a session low of $27.70 after a volatile open. The plunge follows mixed signals: groundbreaking clinical data contrasts with hedge fund exits and financing moves, leaving investors scrambling to parse biotech’s high-stakes balancing act. Institutional Exodus Overshadows Clinical Breakthroughs The collapse stems from two clashing forces: MiNK’s scientific progress and institutional skepticism. While the peer-reviewed Oncogene case study—a complete remission in testicular cancer—validates their iNKT platform, the exodus of top funds like Vanguard and <a data-code="BLK" data-position="stock.2" data-marketid="169" data-stockname="BlackRock" data-type="stock" href="#*f:BLK:sc*#">BlackRock</a> signals caution. The $50M ATM offering, announced alongside the data, further spooked investors, amplifying liquidity concerns. Bulls may cling to the durable response data, but the market is prioritizing near-term execution risks over long-term potential. Technical Contradictions and Defensive Plays • MACD: 6.15 (bullish), RSI: 70.09 (overbought) • Bollinger Bands: Closed below 200-day MA ($5.38) but upper band at $40.62 highlights volatility • Volume: 1.38M shares signal panic selling Technicals paint a fractured picture: overbought RSI warns of exhaustion, while MACD divergence hints at a potential rebound. Aggressive buyers could target $27.70 support, but the broken 200-day MA suggests a bearish bias. With no liquid options contracts available, focus on the $28–$30 range as a buy-the-dip zone. Watch for resistance at $34.50 (intraday high) before considering short positions. *Action Alert: Short sellers may target the $28.50 level using inverse ETFs if the biotech sector weakens further. <visualization data="&quot;&quot;"></visualization> Backtest MiNK Therapeutics Stock Performance MiNK Therapeutics (INKT) experienced a significant intraday plunge of -30% on July 14, 2025, following a clinical trial update and a downgrade by William Blair. The stock's performance in the aftermath of the plunge can be described as follows:1. Immediate Reaction to Downgrade: After the downgrade, INKT's stock price fell by 30% on the trading day, which is a common market reaction to a shift in analyst sentiment, especially after a significant surge in price.2. Market Sentiment and Future Outlook: The downgrade by William Blair from Outperform to Market Perform indicates a more cautious outlook on INKT's future performance. The performance of INKT after the -30% intraday plunge has been marked by a continued decline in stock price, reflecting investor uncertainty and the impact of the analyst downgrade.<visualization data="{&quot;components&quot;: [{&quot;show_type&quot;: &quot;container2&quot;, &quot;uuid&quot;: &quot;f13e1bd1-6148-4459-a087-c7202b1083b0&quot;}, {&quot;support_refresh&quot;: false, &quot;show_type&quot;: &quot;jgyKline3&quot;, &quot;title_config&quot;: {&quot;show_type&quot;: &quot;title1&quot;, &quot;data&quot;: {&quot;h1&quot;: &quot;INKT Trend&quot;, &quot;h2&quot;: &quot;&quot;}, &quot;config&quot;: {&quot;display&quot;: true, &quot;txt_style&quot;: 0, &quot;display2&quot;: false, &quot;url&quot;: &quot;&quot;}}, &quot;chart_type&quot;: &quot;&quot;, &quot;data&quot;: {&quot;condition&quot;: &quot;[{\&quot;sonSize\&quot;:2,\&quot;opName\&quot;:\&quot;and\&quot;,\&quot;relatedSize\&quot;:0},{\&quot;sonSize\&quot;:0,\&quot;indexName\&quot;:\&quot; @stock code\&quot;,\&quot;indexProperties\&quot;:[\&quot;EQUAL INKT.O\&quot;],\&quot;indexPropertiesMap\&quot;:{\&quot;EQUAL\&quot;:\&quot;INKT.O\&quot;},\&quot;domain\&quot;:\&quot;abs_ \&quot;,\&quot;relatedSize\&quot;:0},{\&quot;sonSize\&quot;:0,\&quot;indexName\&quot;:\&quot; @Percentage Change\&quot;,\&quot;indexProperties\&quot;:[\&quot; 20250715\&quot;,\&quot; 20250715\&quot;],\&quot;indexPropertiesMap\&quot;:{\&quot; \&quot;:\&quot;20250715\&quot;,\&quot; \&quot;:\&quot;20250715\&quot;},\&quot;domain\&quot;:\&quot;abs_ \&quot;,\&quot;relatedSize\&quot;:0}]&quot;, &quot;status_code&quot;: 0, &quot;chunks_info&quot;: &quot;[]&quot;, &quot;columns&quot;: [{&quot;label&quot;: &quot;hq_code&quot;, &quot;source&quot;: &quot;fixed_index&quot;, &quot;type&quot;: &quot;STR&quot;, &quot;index_name&quot;: &quot;code&quot;, &quot;key&quot;: &quot;code&quot;}, {&quot;unit&quot;: &quot;&quot;, &quot;domain&quot;: &quot;abs_ &quot;, &quot;label&quot;: &quot;code&quot;, &quot;source&quot;: &quot;fixed_index&quot;, &quot;feKey&quot;: &quot;Ticker&quot;, &quot;type&quot;: &quot;STR&quot;, &quot;index_name&quot;: &quot;Ticker&quot;, &quot;key&quot;: &quot;Ticker&quot;, &quot;origin_index&quot;: &quot;stock code&quot;}, {&quot;unit&quot;: &quot;&quot;, &quot;domain&quot;: &quot;abs_ &quot;, &quot;label&quot;: &quot;name&quot;, &quot;source&quot;: &quot;fixed_index&quot;, &quot;feKey&quot;: &quot;Name&quot;, &quot;type&quot;: &quot;STR&quot;, &quot;index_name&quot;: &quot;Name&quot;, &quot;key&quot;: &quot;Name&quot;, &quot;origin_index&quot;: &quot;stock name&quot;}, {&quot;label&quot;: &quot;date&quot;, &quot;feKey&quot;: &quot;Date&quot;, &quot;type&quot;: &quot;DATE&quot;, &quot;index_name&quot;: &quot;Date&quot;, &quot;key&quot;: &quot;Date&quot;, &quot;origin_index&quot;: &quot;Date&quot;}, {&quot;unit&quot;: &quot;%&quot;, &quot;domain&quot;: &quot;abs_ &quot;, &quot;label&quot;: &quot;&quot;, &quot;source&quot;: &quot;&quot;, &quot;feKey&quot;: &quot;Percentage Change&quot;, &quot;type&quot;: &quot;DOUBLE&quot;, &quot;index_name&quot;: &quot;Percentage Change&quot;, &quot;key&quot;: &quot;Percentage Change&quot;, &quot;timestamp&quot;: &quot;&quot;}, {&quot;type&quot;: &quot;STR&quot;, &quot;index_name&quot;: &quot;market_code&quot;, &quot;key&quot;: &quot;market_code&quot;}], &quot;datas&quot;: [{&quot;code&quot;: &quot;INKT&quot;, &quot;Ticker&quot;: &quot;INKT.O&quot;, &quot;market_code&quot;: &quot;186&quot;, &quot;Percentage Change&quot;: &quot;-29.38931297709923&quot;, &quot;Date&quot;: &quot;20250715&quot;, &quot;Name&quot;: &quot;MiNK Therapeutics&quot;}], &quot;meta&quot;: {&quot;extra&quot;: {}}, &quot;dataSize&quot;: 1, &quot;status_msg&quot;: &quot;ok&quot;, &quot;code_count&quot;: 1, &quot;row_count&quot;: 1}, &quot;unique_key&quot;: &quot;3ec2c8023d9e3faa&quot;, &quot;kline&quot;: true, &quot;data_config&quot;: {&quot;data_ext_params&quot;: {&quot;data_add&quot;: 0, &quot;expand_index&quot;: false, &quot;add_index&quot;: 0, &quot;merge_repeat&quot;: false}, &quot;query_type&quot;: &quot;intusstock&quot;}, &quot;category&quot;: &quot;generic&quot;, &quot;renderBy&quot;: &quot;rule&quot;, &quot;config&quot;: {&quot;image&quot;: &quot;https://lh-prod-mid-pub-newsf10.s3.amazonaws.com/logo/INKT.png&quot;, &quot;marketTag&quot;: &quot;NASDAQ&quot;, &quot;show_type_id&quot;: 702, &quot;tradeClass&quot;: &quot;intraday&quot;, &quot;title&quot;: &quot;K V2&quot;, &quot;fsType&quot;: &quot;pre_market&quot;, &quot;showBottom&quot;: true, &quot;score&quot;: 20, &quot;show_type&quot;: &quot;kline3&quot;, &quot;title_config&quot;: {&quot;show_type&quot;: &quot;title1&quot;, &quot;data&quot;: {&quot;h1&quot;: &quot;INKT Trend&quot;, &quot;h2&quot;: &quot;&quot;}, &quot;config&quot;: {&quot;display&quot;: true, &quot;txt_style&quot;: 0, &quot;display2&quot;: false, &quot;url&quot;: &quot;&quot;}}, &quot;variety&quot;: &quot;stock&quot;, &quot;scoreRuleNames&quot;: &quot;&quot;, &quot;tradeStatus&quot;: &quot;trading&quot;, &quot;codeName&quot;: &quot;Name&quot;}, &quot;uuid&quot;: &quot;ba0288f58835cd39&quot;}], &quot;query_condition&quot;: {&quot;domain&quot;: &quot;intusstock&quot;, &quot;uuids&quot;: [&quot;f13e1bd1-6148-4459-a087-c7202b1083b0&quot;, &quot;ba0288f58835cd39&quot;]}, &quot;global&quot;: {&quot;query_type&quot;: &quot;intusstock&quot;}, &quot;data_config&quot;: {&quot;data_ext_params&quot;: {&quot;data_add&quot;: 0, &quot;expand_index&quot;: false, &quot;add_index&quot;: 0, &quot;merge_repeat&quot;: false}, &quot;query_type&quot;: &quot;intusstock&quot;}, &quot;page&quot;: {&quot;layout&quot;: {&quot;layout_data&quot;: &quot;[{\&quot;children\&quot;: [{\&quot;uuid\&quot;: \&quot;ba0288f58835cd39\&quot;, \&quot;children\&quot;: [], \&quot;showType\&quot;: \&quot;\&quot;}], \&quot;showType\&quot;: \&quot;container2\&quot;, \&quot;uuid\&quot;: \&quot;f13e1bd1-6148-4459-a087-c7202b1083b0\&quot;}]&quot;}, &quot;render_for&quot;: &quot;aigc&quot;, &quot;language&quot;: &quot;tr&quot;}}"></visualization> Hold or Fold? MiNK’s Critical Crossroads This bloodbath isn’t over. While MiNK’s iNKT platform remains a game-changer in solid tumor therapy, the market is demanding proof beyond single-patient case studies. The $50M ATM offering and hedge fund withdrawals create near-term headwinds, but a successful Phase 2 gastric cancer data readout could spark a rebound. Monitor GILD’s -2.5% pullback for sector sentiment—if it holds, MiNK’s $27.70 floor might hold too. Investors should brace for volatility: buy dips below $30 with strict stop-losses, but wait for hard clinical data before going all-in.

MiNK Therapeutics Plummets 30%—What's Driving the Sell-Off?

Comentarios